.png){kind=icon}
.png){kind=icon}
Return
Age‐adapted chemotherapy and MRD‐oriented transplant for Ph-negative acute lymphoblastic leukemia - GRAALL-2014 trial
.png){kind=icon}
PRE
AI
N
S
F
T
M
C
Y
É
Y
P
M
C
M
F
M
A
A
N
É
C
S
G
A
M
T
P
P
B
N
M
M
W
N
V
V
E
H
DOI：10.1182/blood.2025029611.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
- In patients over 45 years old, age-adapted protocol improved complete remission rate and decreased non-relapse mortality - MRD-based transplant decisions reduced transplant indications and ensured the procedure was limited to patients most likely to benefit
Journal
IF:
23.1
Papers:
5.4K
Citations:
16.6W
Organization
A
View more organizations